Alice Chen net worth
Quick answer
Alice Chen's estimated net worth is $5.65M (range $3.95M – $8.47M) as of 2026. Alice Chen is Founder at Trestle Biotherapeutics. Trestle Biotherapeutics valuation.
Alice Chen is Founder at Trestle Biotherapeutics (YC W21). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Background: Chinese, Asian
- Education: Harvard University, Stanford University
- Region: United States of America
- Industries: Healthcare, Industrial Bio
- Team size: 2
- Website: http://www.trestlebio.com
Who is Alice Chen?
Alice Chen is a co-founder of Trestle Biotherapeutics, a company focused on developing novel therapeutics. She is an alumna of the Y Combinator startup accelerator.
Highlights:
- Y Combinator
- Harvard University
- Stanford University
Background
Heritage labels inferred from name patterns only — not verified. Heritage/background labels may be inferred and are not verified identity documents.
About Trestle Biotherapeutics
We are developing an implantable therapeutic tissue that will be surgically delivered to patients suffering from end stage renal disease. Upon implantation, this tissue will supplement the patient's renal function, eliminating their dependency on dialysis and improving their disease status. This has the potential to not only get these patients off dialysis - a significant impact for them and their families - but...
FAQ: Alice Chen net worth and Trestle Biotherapeutics valuation
What is Alice Chen's net worth?
Alice Chen's estimated net worth is $5.65M (range $3.95M – $8.47M) as of 2026. Alice Chen is Founder at Trestle Biotherapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Trestle Biotherapeutics valuation?
Trestle Biotherapeutics's estimated valuation on Entrepreneurial Check is $11.3M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Alice Chen's role?
Alice Chen is Founder at Trestle Biotherapeutics, a Y Combinator-backed startup (batch W21).